Analysis of Ingredients of Supplements in the National Institutes of Health Supplement Database Marketed as Containing a Novel Alternative to Anabolic Steroids

Pieter A Cohen; Joshua Sharfstein; Angélique Kamugisha; Céline Vanhee

doi:10.1001/jamanetworkopen.2020.2818

Analysis of Ingredients of Supplements in the National Institutes of Health Supplement Database Marketed as Containing a Novel Alternative to Anabolic Steroids

JAMA Netw Open. 2020 Apr 1;3(4):e202818. doi: 10.1001/jamanetworkopen.2020.2818.

Authors

Pieter A Cohen^{1

2}, Joshua Sharfstein³, Angélique Kamugisha⁴, Céline Vanhee⁴

Affiliations

¹ Department of Medicine, Cambridge Health Alliance, Somerville, Massachusetts.
² Harvard Medical School, Boston, Massachusetts.
³ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁴ Department of Medicines and Health Products, Sciensano, Brussels, Belgium.

Abstract

This case series analyzes whether supplements categorized as containing novel ingredients in the National Institutes of Health Dietary Supplement Label Database are accurately labeled.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Dietary Supplements / analysis*
Dietary Supplements / standards*
Drug Labeling / standards*
Humans
National Institutes of Health (U.S.)
Testosterone Congeners / chemistry*
Testosterone Congeners / standards*
United States

Substances

Testosterone Congeners